BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37150673)

  • 21. AMPK mediates regulation of glomerular volume and podocyte survival.
    Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
    Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
    Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
    PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of calcitriol and methylprednisolone on podocytes function in minimal change disease in vitro model.
    Grubczak K; Starosz A; Makowska B; Parfienowicz Z; Krętowska M; Naumnik B; Moniuszko M
    Sci Rep; 2023 Aug; 13(1):12731. PubMed ID: 37543700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
    Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrin Signaling Results in Integrin
    Dlugos CP; Picciotto C; Lepa C; Krakow M; Stöber A; Eddy ML; Weide T; Jeibmann A; P Krahn M; Van Marck V; Klingauf J; Ricker A; Wedlich-Söldner R; Pavenstädt H; Klämbt C; George B
    J Am Soc Nephrol; 2019 Jun; 30(6):1006-1019. PubMed ID: 31097607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Mouse Model of Idiopathic Nephrotic Syndrome Induced by Immunization with the Podocyte Protein Crb2.
    Hada I; Shimizu A; Takematsu H; Nishibori Y; Kimura T; Fukutomi T; Kudo A; Ito-Nitta N; Kiuchi Z; Patrakka J; Mikami N; Leclerc S; Akimoto Y; Hirayama Y; Mori S; Takano T; Yan K
    J Am Soc Nephrol; 2022 Nov; 33(11):2008-2025. PubMed ID: 35985815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyte proteins in congenital and minimal change nephrotic syndrome.
    Suvanto M; Jahnukainen T; Kestilä M; Jalanko H
    Clin Exp Nephrol; 2015 Jun; 19(3):481-8. PubMed ID: 25117488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models.
    Embry AE; Liu Z; Henderson JM; Byfield FJ; Liu L; Yoon J; Wu Z; Cruz K; Moradi S; Gillombardo CB; Hussain RZ; Doelger R; Stuve O; Chang AN; Janmey PA; Bruggeman LA; Miller RT
    J Am Soc Nephrol; 2018 May; 29(5):1501-1512. PubMed ID: 29572404
    [No Abstract]   [Full Text] [Related]  

  • 32. LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile.
    Srivastava T; Sharma M; Yew KH; Sharma R; Duncan RS; Saleem MA; McCarthy ET; Kats A; Cudmore PA; Alon US; Harrison CJ
    J Cell Commun Signal; 2013 Mar; 7(1):49-60. PubMed ID: 23161414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease.
    Li JS; Chen X; Peng L; Wei SY; Zhao SL; Diao TT; He YX; Liu F; Wei QJ; Zhang QF; Li B
    PLoS One; 2015; 10(9):e0137049. PubMed ID: 26352670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
    Srivastava T; Garola RE; Singh HK
    Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury.
    Zhou H; Tian X; Tufro A; Moeckel G; Ishibe S; Goodwin J
    Sci Rep; 2017 Aug; 7(1):9833. PubMed ID: 28852159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
    Fujino T; Hasebe N
    BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome.
    Ogawa-Akiyama A; Sugiyama H; Kitagawa M; Tanaka K; Kano Y; Mise K; Otaka N; Tanabe K; Morinaga H; Kinomura M; Uchida HA; Wada J
    PLoS One; 2020; 15(1):e0228337. PubMed ID: 31978139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deiodinase-3 is a thyrostat to regulate podocyte homeostasis.
    Agarwal S; Koh KH; Tardi NJ; Chen C; Dande RR; WerneckdeCastro JP; Sudhini YR; Luongo C; Salvatore D; Samelko B; Altintas MM; Mangos S; Bianco A; Reiser J
    EBioMedicine; 2021 Oct; 72():103617. PubMed ID: 34649077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.